[go: up one dir, main page]

SU1380209A1 - RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE - Google Patents

RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE

Info

Publication number
SU1380209A1
SU1380209A1 SU4093231/13A SU4093231A SU1380209A1 SU 1380209 A1 SU1380209 A1 SU 1380209A1 SU 4093231/13 A SU4093231/13 A SU 4093231/13A SU 4093231 A SU4093231 A SU 4093231A SU 1380209 A1 SU1380209 A1 SU 1380209A1
Authority
SU
USSR - Soviet Union
Prior art keywords
pur
recombinant plasmid
hepatitis virus
hav
antigenic determinants
Prior art date
Application number
SU4093231/13A
Other languages
Russian (ru)
Inventor
Ю.А. Овчинников
Е.Д. Свердлов
С.А. Царев
Т.О. Рохлина
Т.Л. Ажикина
С.Г. Арсенян
Ю.Ю. Кусов
В.И. Грабко
Т.А. Насташенко
М.С. Балаян
С.Г. Дроздов
В.Е. Чижиков
Н.А. Петров
С.К. Василенко
Г.Г. Приходько
Original Assignee
Институт биоорганической химии им.М.М.Шемякина
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт биоорганической химии им.М.М.Шемякина filed Critical Институт биоорганической химии им.М.М.Шемякина
Priority to SU4093231/13A priority Critical patent/SU1380209A1/en
Application granted granted Critical
Publication of SU1380209A1 publication Critical patent/SU1380209A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

FIELD: biotechnology. SUBSTANCE: new recombinant plasmid pUR 291-HAV 22 consists of the Pst-linearized plasmid pUR 291, sequence of hepatitis virus A genome (size is 389 base pairs) encoding protein VBI. EFFECT: making of new recombinant plasmid providing expression of hepatitis virus A antigenic determinants in the cells of E coli. 2 tbl, 1 dwg
SU4093231/13A 1986-07-31 1986-07-31 RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE SU1380209A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4093231/13A SU1380209A1 (en) 1986-07-31 1986-07-31 RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4093231/13A SU1380209A1 (en) 1986-07-31 1986-07-31 RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE

Publications (1)

Publication Number Publication Date
SU1380209A1 true SU1380209A1 (en) 1994-12-30

Family

ID=60517577

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4093231/13A SU1380209A1 (en) 1986-07-31 1986-07-31 RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE

Country Status (1)

Country Link
SU (1) SU1380209A1 (en)

Similar Documents

Publication Publication Date Title
BG60107B2 (en) Method for the preparation of eukaryotic polypeptide
CA2020668A1 (en) Fused or hybrid protein comprising viral antigen and lymphokine
DK577783A (en) VECTOR FOR EXPRESSION OF A DNA SEGMENT IN GAER
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
GR852592B (en)
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
DE3686579D1 (en) Prokaryotisches expressionssystem.
EP0216564A3 (en) Infectious recombinant virus, vaccines containing said virus for feline leukemia, and methods for the production thereof
DK192189A (en) POLYPEPTIDE, PROCEDURE FOR INHIBITING THE FIBRINOGEN, PROCEDURE FOR PURIFYING A POLYPEPTIDE, GENES CONTAINING RECOMBINANT DNA CODING FOR A POLYPEPTIDE, VECTOR, CELL CULTURE AND PROCESSING PROCEDURE
EP2044950A3 (en) Attenuated VIF DNA immunization cassettes for genetic vaccines
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
EP0152030A3 (en) Adult t cell leukemia virus antigen polypeptide
FI885296A0 (en) RECOMBINANT HIV-2 POLYPEPTIDES.
HUT67302A (en) Recombinant adenovirus vaccines
ZA935117B (en) Anti-feline immunodeficiency virus (FIV) vaccines
EP0432220A4 (en) Vaccines and diagnostic assays for haemophilus influenzae
DK498387D0 (en) Viral DNA SEQUENCE
SU1380209A1 (en) RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE
WO1988000973A1 (en) Recombinant plasmid dnas, coding for synthesis of polypeptide substances for a vaccine against hepatitis a
SU1515698A1 (en) Recombinant plasmid dna encoding synthesis of hbs ag hepatitis virus b, and a strain of vaccine virus - a producer of hbs ag hepatitis virus b
PT89041A (en) Purified hepatitis C virus - and associated nucleic acids and polypeptide(s)
ATE52798T1 (en) RECOMBINANT PLASMID CONTAINING HEPATITIS B VIRUS GENE, YEAST TRANSFORMED WITH SUCH RECOMBINANT PLASMID AND PRODUCTION OF HEPATITIS B VIRUS SURFACE ANTIGEN.
JPS6485094A (en) Novel physiologically active polypeptide